This federal contract award, with an ID of SPE2DB22D1200|SPE2DB25FM9RA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,236.27 firm fixed-price delivery order is for the drug Skyrizi (150 mg/ml), a specialty medication used to treat certain medical conditions. The contract has a period of performance through December 2024.
Amerisourcebergen is the prime contractor on this award, which is not designated as a set-aside contract. The company maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024. These IDCs allow the government to efficiently procure a wide range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.
Generated 3/24/25, 9:45 AM